HUMAN GENOME SCIENCES INC Spending and interest coverage
- R&D / revenue · 12 months: Value 81.97%; Formula and calculation Research and development expense / revenue. Period ending 2012-06-30..
- Stock-based compensation / revenue · 12 months: Value 22.58%; Formula and calculation Share-based compensation / revenue. Period ending 2012-06-30..
- Interest coverage · 12 months: Value -4.22×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2012-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 81.97% | Research and development expense / revenue. Period ending 2012-06-30. $153.30M ÷ $187.01M × 100 ≈ 81.97% |
| Stock-based compensation / revenue · 12 months | 22.58% | Share-based compensation / revenue. Period ending 2012-06-30. $42.23M ÷ $187.01M × 100 ≈ 22.58% |
| Interest coverage · 12 months | -4.22× | Operating income ÷ reported interest expense. $-296.43M ÷ $70.23M ≈ -4.22× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 153.30M USD | Research and Development Expense |
| Revenue | 187.01M USD | |
| Stock-based compensation | 42.23M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -296.43M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 70.23M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2012-06-30 | $153.30M | $187.01M | $42.23M | $-296.43M | $70.23M | 81.97% | 22.58% | -4.22× | Reported |
| 2012-03-31 | $151.27M | $151.53M | $40.09M | $-289.74M | $66.16M | 99.83% | 26.46% | -4.38× | Reported |
| 2011-12-31 | $196.18M | $130.97M | $35.91M | $-329.55M | $62.06M | 149.79% | 27.42% | -5.31× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $205.40M | $123.47M | $29.66M | $-290.50M | $60.77M | 166.35% | 24.02% | -4.78× | Reported |
| 2011-03-31 | $223.38M | $137.41M | $28.20M | $-269.00M | $60.11M | 162.57% | 20.52% | -4.48× | Reported |
| 2010-12-31 | $196.37M | $157.35M | $25.43M | $-190.77M | $59.50M | 124.80% | 16.16% | -3.21× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $173.71M | $275.75M | $12.52M | $6.19M | $58.42M | 63.00% | 4.54% | 0.11× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.